Efficacy and Safety of the Treatment of Primary Membranous Nephropathy: A Randomized Clinical Trial

Condition:   Efficacy and Safety Interventions:   Drug: Rituximab combined with tacrolimus induction + rituximab maintenance;   Drug: Rituximab combined with tacrolimus induction + tacrolimus maintenance;   Drug: Glucocorticoid combined with cyclophosphamide induction + maintenance Sponsor:   RenJi Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials